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Abstract
Background: Most children and adolescents diagnosed with cancer become long-term survivors. For most of them, regular
follow-up examinations to detect and treat late effects are necessary, especially in adulthood. The transition from pediatric to
adult-focused follow-up care is a critical moment for childhood cancer survivors (CCSs); a substantial proportion of CCSs are
lost to follow-up in this transition process and do not attend follow-up care in adulthood. This can have serious effects on survivors’
health if late effects are not discovered in a timely fashion.
Objective: In this study, we primarily assess the current follow-up situation, related needs, and knowledge of adolescent and
young adult CCSs who have transitioned from pediatric to adult-focused follow-up care. As secondary objectives, we evaluate
transition readiness, identify facilitating factors of transition and adherence to long-term follow-up (LTFU) care, and compare
three different transition models.
Methods: The Aftercare of Childhood Cancer Survivors (ACCS) Switzerland study is a prospective, multicenter, observational
study that was approved by the ethics committee in February 2019. We are recruiting CCSs from three pediatric oncology centers
and using questionnaires to answer the study questions.
Results: To date, we have recruited 58 participants. The study is ongoing, and recruitment of participants will continue until
January 2021.
Conclusions: The ACCS study will provide information on CCSs’ preferences and expectations for follow-up care and their
transition into the adult setting. The results will help improve the LTFU care and cancer knowledge of CCSs and subsequently
enhance adherence to follow-up care and reduce loss to follow-up in adulthood.
Trial Registration: ClinicalTrials.gov NCT04284189; https://clinicaltrials.gov/ct2/show/NCT04284189?id=NCT04284189
International Registered Report Identifier (IRRID): PRR1-10.2196/18898
(JMIR Res Protoc 2020;9(8):e18898) doi: 10.2196/18898
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Introduction
Background
Most children and adolescents diagnosed with cancer become
long-term survivors and need lifelong follow-up care [1].
Childhood cancer survivors (CCSs) are vulnerable to physical
and psychosocial chronic medical conditions, so-called late
effects. Some late effects are characteristic of CCSs, while most
of them are also associated with aging in the general population
but develop earlier in CCSs. Three out of four 5-year CCSs
treated between 1966 and 1996 with a median follow-up time
of 17 years experienced at least one late effect, 37% of which
may be life threatening [2]. The goal of follow-up care is to
detect late effects early and to intervene, treat, or slow their
progression. Finally, follow-up care aims to reduce the burden
of late effects and improve CCSs’ quality of life. Studies show
that long-term follow-up (LTFU) care improves the detection
of late effects and survivors’ health behavior and knowledge,
encourages health care use, and decreases survivors’ distress
levels [3].
As CCSs reach adulthood, questions and issues arise that
pediatric oncologists are no longer expert in addressing and,
therefore, adult physicians are needed. This process of change
in health and follow-up care is known as transition. Transition
has been described as the planned movement of adolescent and
young adult (AYA) patients with chronic health conditions from
child-centered to adult-oriented health care systems. The
preparation of adolescents for transition should start several
years before the actual transition occurs. Adolescents need to
acquire the knowledge and skills to assume independent
responsibility for their health care in the adult system. The
process of transition ideally should address medical,
psychosocial, and vocational needs. During transition, care
shifts from family-centered pediatric to independent
patient-centered health care as survivors enter adulthood. The
transition of CCSs is a critical moment in LTFU care that may
affect survivors’ LTFU clinic attendance and may cause loss to
follow-up [4-7]. There is a clear and steady decrease in the
proportion of CCSs who attend a clinic visit as time since
treatment completion increases [4]. This is particularly
concerning since CCSs are at greater risk of late effects as time
passes [8,9]. One reason for loss to follow-up seems to be CSSs’
lack of knowledge regarding their diagnosis, treatment, and risk
of developing late effects [10,11]. This factor can be influenced
by educating CCSs. Another reason is the lack of knowledge
about late effects and the need for further follow-up
examinations with adult physicians who should provide this
care [12].
To date, it is not clear which transition and LTFU care model
is the best based on the existing health care system. Many
different models of LTFU care exist: (1) models calling for
transition to primary care physicians, (2) shared-care models
with LTFU care provided by the primary care physician in
collaboration with the oncology team, (3) models suggesting
transition from pediatric to adult oncologists, or (4) models
proposing transition to specialized LTFU clinics, which provide
LTFU care in multidisciplinary teams [13,14]. In addition to
the debate surrounding the model of LTFU care, there is debate
on the right time point of transition. Some study groups have
developed and used scores to assess the transition readiness of
AYA patients with chronic diseases, such as inflammatory
bowel disease [15], cystic fibrosis [16], or congenital heart
disease [17]. Klassen et al developed tools to assess CCSs’
readiness for transition [18], and Schwartz et al are currently
developing a Transition Readiness Inventory Item Pool, which
measures socioecological components relevant for successful
transition [19]. However, evidence collected prospectively
during the transition process addressing the needs of young
adult CCSs during their transition into adult LTFU care in
different settings is limited.
Nine pediatric oncology centers treat children and adolescents
up to the age of 18 years diagnosed with cancer in Switzerland.
Like the initial treatment, follow-up care is provided in these
nine centers until at least the age of 18 years and usually for
longer. A recent survey including the division head or the
responsible staff physician for follow-up care of each of the
nine centers showed differences in follow-up care between
centers, especially concerning transition [20]. These differences
were also noted in the current position statement from the
Pediatric Swiss Long-Term Follow-Up Working Group [21].
This working group aims to achieve harmonization between the
centers. Both publications reflect the current situation of
physicians in Switzerland, but the needs of Swiss CCSs are still
unknown.
Objectives
The primary objectives of the Aftercare of Childhood Cancer
Survivors (ACCS) Switzerland study are to assess the current
follow-up situation, related needs, and knowledge of AYA
survivors of childhood cancer undergoing LTFU care transitions
from pediatric to adult-focused follow-up care. By including
three pediatric oncology centers with different transition and
LTFU care models, we aim to investigate which model or which
parts of the models have the best fit for Swiss CCSs. As
secondary objectives, we aim to evaluate the transition readiness
of CCSs, identify facilitating factors for transition and adherence
to LTFU care, and compare the transition models of the three
participating centers. The results of this study are intended to
serve as a basis to improve transition and LTFU care in
Switzerland and could be transferrable to countries with similar
health care systems.
Methods
Study Design
The ACCS study is a prospective, multicenter, observational
study and is registered at ClinicalTrials.gov (NCT04284189).
Setting: Transition and LTFU Care Models in
Participating Clinics
We included three pediatric oncology centers with different
transition and LTFU care models—Center 1: Department of
Pediatrics, Kantonsspital Luzern; Center 2: University
Children’s Hospital Basel; and Center 3: Department of
Pediatrics, Kantonsspital Aarau. All three centers are very
similar in terms of the geographical catchment area, number of
JMIR Res Protoc 2020 | vol. 9 | iss. 8 | e18898 | p. 2http://www.researchprotocols.org/2020/8/e18898/
(page number not for citation purposes)
Denzler et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
new diagnoses per year, and location of the adult hospital on
the same campus. Center 1 refers most CCSs to the primary
care physician but does not systematically make these referrals
when CCSs reach a certain age or time since the completion of
treatment. Some CCSs with already symptomatic late effects
are transitioned to adult oncology. Center 2 transitions all CCSs
to adult oncology and has done so since 2014. Their model
includes one joint visit at the age of 18 years during which the
adult oncologist or hematologist attends part of the pediatric
clinic visit. The following visit takes place in the adult hospital
with the adult oncologist or hematologist only. The transition
model of Center 3 involves a transition process over a minimum
of two clinical visits. The transition team, consisting of a
designated pediatric oncologist and adult oncologist or
hematologist, attends both appointments for the whole
consultation time. The first visit takes place in the pediatric
hospital, and the second visit takes place in the adult hospital.
If the CCS feels comfortable, the third appointment is attended
by the adult oncologist or hematologist only, but the pediatric
oncologist is still available in case of specific questions.
Eligibility Criteria and Group Assignment
CCSs are eligible to participate in the ACCS study if it has been
at least 5 years since completion of their treatment, either
first-line treatment or treatment for relapsed disease; if they
were diagnosed with cancer according to the International
Childhood Cancer Classification, third edition (ICCC3); if they
were less than 18 years of age at cancer diagnosis; and if they
are 16 years of age or older at the time of inclusion in the ACCS
study. In addition, CCSs have to either be ready to transition
from pediatric to adult-focused LTFU care (group 1) or already
have been transitioned since 2014 (group 2). We chose the year
2014 because the standardized transition into adult oncology in
Center 2 was established in that year. We exclude CCSs treated
with surgery only and with no increased risk for late effects (eg,
teratoma), those with ongoing cancer treatment or in a palliative
situation, those with cognitive disabilities that would prevent
the CCS from completing a questionnaire, and those not fluent
in speaking and reading German.
Recruitment Overview
We received approval from the cantonal ethics committee
(Ethikkommission Nordwest- und Zentralschweiz) that is
responsible for all three participating centers in February 2019
and started patient recruitment at all three study centers
immediately following the approval. We plan to recruit
participants over a period of 2 years, and we expect to have the
results of the analyses of the questionnaires by autumn 2021.
The local investigator at each of the three sites is responsible
for patient recruitment. After study initiation, each local
investigator prepared a list with all eligible survivors for group
1 and group 2. During the recruitment period, each local
investigator will include additional CCSs who meet the
eligibility criteria.
Recruitment and Study Time Points for Group 1
Childhood Cancer Survivors
Group 1 CCSs receive the study material by mail before their
next scheduled visit at the pediatric LTFU clinic. The study
material consists of an information letter, the informed consent
form, the baseline questionnaire, a reply sheet to return if they
do not want to participate, and a prepaid envelope to return the
study documents before the next visit if they do want to
participate. If an eligible CCS does not reply before the visit,
the local investigator reminds him or her before the LTFU visit,
and he or she still has the opportunity to participate. All group
1 CCSs receive the baseline questionnaire before the LTFU
visit and the follow-up questionnaire 3 months after the LTFU
visit. Group 1a consists of CCSs who decide to transition into
adult care (see Figure 1). They receive a second follow-up
questionnaire approximately 15 months after the first visit. An
interval of 15 months was chosen because most survivors have
roughly one LTFU visit per year. Therefore, with an interval of
15 months, the follow-up questionnaire is sent 3 months after
the first visit in an adult setting. Whenever possible, we adapt
the time at which the second follow-up questionnaire is sent
according to the actual date of the follow-up visit in the adult
setting. Group 1b consists of CCSs who decide during the LTFU
visit to stay in pediatric follow-up care for another year (see
Figure 2). They receive only the baseline questionnaire and first
follow-up questionnaire after 3 months, which provide us with
important information on transition readiness, related needs,
and cancer knowledge.
The local investigators send one reminder only if the CCS does
not respond within 4 weeks to the first and second follow-up
questionnaires.
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Figure 1. Timeline of the Aftercare of Childhood Cancer Survivors (ACCS) study and time points where group 1a participants answer questionnaires;
questionnaire sections are numbered and identical numbers correspond to identical content.
Figure 2. Timeline of the Aftercare of Childhood Cancer Survivors (ACCS) study and time points where group 1b participants answer questionnaires;
questionnaire sections are numbered and identical numbers correspond to identical content.
Recruitment of Group 2 Childhood Cancer Survivors
The local investigators contact group 2 CCSs who have already
left pediatric follow-up care at the start of the study. The time
since transition might range from 3 months to 6 years (see Figure
3). These CCSs receive the study material by mail and a
maximum of one reminder if they do not reply within 4 weeks.
Group 2 CCSs receive only one baseline questionnaire. The
information provided by group 2 CCSs is crucial to assess cancer
knowledge and needs related to transition and LTFU care in
adult CCSs. In addition, comparing the answers of former and
currently transitioned CCSs will enable us to evaluate whether
transition practices in each participating center improved over
time from the CCS point of view.
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Figure 3. Timeline of the Aftercare of Childhood Cancer Survivors (ACCS) study and time point where group 2 participants answer the questionnaire.
Data Collection and Questionnaire Content
Baseline Questionnaires for Childhood Cancer Survivors
All participants receive a baseline questionnaire, which is largely
identical for survivors in group 1 and group 2: Baseline
questionnaire group 1 and Baseline questionnaire group 2. The
baseline questionnaires provide us with information on CCSs’
cancer knowledge, current follow-up situation, and needs. In
both groups, we collect data on CSSs’ current age, sex, highest
completed or ongoing education level, and the subjective
assessment of current health status. We assess CCSs’knowledge
on their cancer diagnosis, treatment modalities received, and
potential late effects using questions with the answer options
“yes,” “no,” and “unsure.” Subsequently, we assess cancer
worry, self-management skills, and expectations for follow-up
care using validated scales. The Cancer Worry Scale consists
of six questions on how much CCSs worry about their cancer
history, relapse, fertility, late effects, and secondary malignancy
[18]. The Self-Management Skill Scale consists of 15 questions,
which cover factors important for evaluating CCSs’
independence and personal responsibility [18]. The 12 questions
of the Expectations Scale cover a broad spectrum of expectations
concerning the treatment team and organizational or structural
processes in the clinics [18]. For all three scales, the questions
use Likert response scales with the following options: “strongly
disagree,” “disagree,” “agree,” and “strongly agree.”
The baseline questionnaire of group 2 CCSs contains one
additional question that the group 1 baseline questionnaire does
not contain, which asks about the current follow-up situation.
The response indicates whether the CCS is continuing with
follow-up care and either where the follow-up care takes place
or why the CCS discontinued follow-up care.
Follow-Up Questionnaires for Childhood Cancer
Survivors
The first follow-up questionnaire for group 1 CCSs, including
groups 1a and 1b, only asks about cancer knowledge. The
content of the second follow-up questionnaire is identical to
that of the baseline questionnaire of group 2 CCSs.
Collection of Medical Data
We collect medical data using a questionnaire completed by
the local investigators. The local investigators answer five
questions regarding tumor diagnosis: main category of cancer
diagnosis (eg, leukemia), diagnosis according to the ICCC3,
tumor location, whether the patient has suffered from a relapse,
and patient’s age at diagnosis. In addition, the local investigators
indicate CCSs’ treatment exposure and organ-specific risks for
late effects. The local investigators extract these data from
medical records.
Data Management
For electronic acquisition of the paper-based questionnaires,
we use the software Remark Office OMR (Gravic, Inc). After
each questionnaire version has been edited with the software,
the software recognizes the selected answers on the completed
documents and saves the answers electronically. The software
traces changes in the database via an audit trail. The data stored
in Remark Office OMR can be exported as Excel documents,
which allows further processing of the data by statistical
software, such as Stata (StataCorp LLC) and R (The R
Foundation).
Statistical Analysis
The ACCS study has two analytical approaches: a
cross-sectional approach and a longitudinal approach. The
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cross-sectional approach includes analysis of the baseline
questionnaire from group 2 CCSs and the second follow-up
questionnaire from group 1 CCSs. Both questionnaires contain
the same questions and answer options, with the exception of
the “Current follow-up situation” question, which is asked only
for group 2 CCSs. For the cross-sectional approach, we will
present the results mainly descriptively (ie, mean and median
with an appropriate measure of spread as well as summary tables
and graphs), for example, the distribution of the four answer
options for the questions on cancer worries. Additionally, we
will quantify the associations between survivors’ worries or
expectations regarding follow-up care and diagnosis, treatment
exposure, or the risk of developing late effects based on specific
parameters such as odds ratio with respective measures of
distribution.
The longitudinal approach includes the analysis of
questionnaires from group 1 CCSs who answer at least one
follow-up questionnaire. The answers from the group 1a and
1b CCSs can be used to determine whether follow-up
consultation improves cancer knowledge. For the analysis of
CCSs’ satisfaction and expectations over time, we will use data
from group 1b CCSs who answer the baseline and second
follow-up questionnaire. In addition to using descriptive analysis
as in the cross-sectional approach, we will use analysis of
covariance in the longitudinal approach, whereby the result of
the baseline questionnaire will serve as a covariate in the model
for the result of the second follow-up questionnaire. In addition,
we will analyze and discuss the different transition models
taking into account the follow-up situation of each center when
the project started. We will use the statistical software programs
Stata and R.
Results
To date, we have recruited 58 CCSs in total, with 33 participants
from the Division of Oncology-Hematology at Kantonsspital
Aarau. We use this center to provide a practical illustration of
the recruitment process and the current status. The center invited
72 CCSs to participate in the study in the first year. A total of
33 CCSs (46%) have confirmed their participation and
completed the baseline questionnaire. A total of 19 of these
CCSs are in group 1 and have already completed the first
follow-up questionnaire, and 14 CCSs belong to group 2. Of
the remaining 39 CCSs, 10 were recently contacted for the first
time, whose responses are still pending, and 16 did not respond;
of these 16 nonresponders, 5 stated no interest in the study, 2
could not be included due to medical reasons, 2 did not show
up for the visit, and 1 stated insufficient time for participation.
The recruitment will continue until January 2021.
Discussion
Overview
In this study, we will assess the follow-up situation, related
needs, and knowledge of AYA cancer survivors who transition
from pediatric to adult-focused follow-up care. We will evaluate
their transition readiness, identify facilitators for transition and
adherence to LTFU care, and compare the transition models of
the three participating centers.
Strength and Limitations
This is the first study in Switzerland assessing CCSs’needs and
perceptions of transition and LTFU care using a prospective,
multicenter, observational approach. The survivors’ feedback
on the study has been mostly positive. At this preliminary state,
we assume that the questionnaires are understandable and easy
to complete, as most participants have completed all questions,
and no questions regarding content have arisen during the clinic
visits. Remark Office OMR is an easy-to-use tool for scanning
and analyzing questionnaires, as it eliminates the need to
manually transcribe the original questionnaires.
The questionnaire-based design might introduce selection bias,
as CCSs who are interested in LTFU care are potentially more
willing to participate than those who are not interested. For
CCSs who are still in follow-up care, social desirability bias
might positively influence their answers and prevent them from
being critical. The interval between the last LTFU care visit to
the completion of the questionnaire among the group 2 CCSs
is variable and ranges theoretically from 3 months to 6 years
(inclusion starts from 2014 onward).
Lessons Learned
Setting up and participating in a prospective study requires the
willingness of all local investigators to continuously work on
the project. For the ACCS study, this means always thinking
about CCSs who are potentially eligible to participate in the
study and sending them the documents, reminders, and
follow-up questionnaires. Close collaboration and site visits by
the primary investigator are essential. Regarding patient
recruitment, we have learned that some CCSs prefer oral
information to written information. We noticed this during the
clinical visits when we asked survivors eligible for group 1 who
had not returned the documents beforehand why they had not
returned them. By providing oral information, we could recruit
more participants. It is, therefore, worthwhile to talk to the
survivors personally about the planned study.
Conclusions
The ACCS study collects detailed information on CCSs’
preferences and expectations regarding LTFU care and the
transition into the adult setting. We need these results to adapt
LTFU care to CCSs’ needs and to identify areas where targeted
interventions are possible, such as patient education. Through
this approach and a subsequent well-structured, standardized
transition focused on the survivor’s needs, adherence to LTFU
care can be improved and loss to follow-up can be reduced.
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